Hypertension Grading & Treatment Initiation — free guideline decision tool
This tool grades office hypertension and, combined with cardiovascular risk, gives the timing of drug initiation and the blood-pressure target per the 2024 Chinese hypertension guideline.
Open guideline tool →Guideline-based
Implements the decision logic from published clinical guidelines.
Runs in your browser
No installation. Enter the patient's values and get a guideline recommendation instantly.
Data stays local
Nothing is uploaded. Results are for licensed clinicians only.
Common questions
What does Hypertension Grading & Treatment Initiation do?
Use to decide when to start antihypertensives — immediately for Grade 3 or high/very-high risk, after a lifestyle trial otherwise — and to set the BP target by age and comorbidity.
How is the result calculated?
Grade by BP (1: 140–159/90–99; 2: 160–179/100–109; 3: ≥ 180/110; high-normal 130–139/85–89). High/very-high risk or Grade 3 → start now; moderate → weeks of lifestyle; low → 1–3 months. Target generally < 140/90 (< 130/80 if tolerated or with diabetes/CKD/coronary disease).
Is this a substitute for clinical judgement?
No. All results are decision-support only, for licensed clinicians. They must be individualized to the whole patient and the latest guideline version.
Run Hypertension Grading & Treatment Initiation now
This tool grades office hypertension and, combined with cardiovascular risk, gives the timing of drug initiation and the blood-pressure target per the 2024 Chinese hypertension guideline.
Open guideline tool →For licensed clinicians. Not a substitute for clinical judgement.